The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Progress in the treatment of advanced gastric cancer
Open accessAbstract
Gastric cancer is one of the most common malignant tumors in the digestive system. Surgery is currently considered to be the only radical treatment. As surgical techniques improve and progress is made in traditional radiotherapy, chemotherapy, and the implementation of neoadjuvant therapy, the 5-year survival rate of early gastric cancer can reach >95%. However, the low rate of early diagnosis means that most patients have advanced-stage disease at diagnosis and so the best surgical window is missed. Therefore, the main treatment for advanced gastric cancer is the combination of neoadjuvant chemoradiotherapy, molecular-targeted therapy, and immunotherapy. In this article, we summarize several common methods used to treat advanced gastric cancer and discuss the progress made in the treatment of gastric cancer in detail. Only clinical practice and clinical research will allow us to prolong the survival time of patients and allow the patients to truly benefit by paying attention to the individual patient characteristics, drug choice, and developing a reasonable and comprehensive treatment plan.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ohtsu, A., Shah, M. A., Van Cutsem, E., Rha, S. Y., Sawaki, A., Park, S. R., Lim, H. Y., Yamada, Y., Wu, J., Langer, B., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.2236 · Cited by 1,110
Waddell, T., Chau, I., Cunningham, D., Gonzalez, D., Okines, A. F. C., Wotherspoon, A., Saffery, C., Middleton, G., Wadsley, J., Ferry, D., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70096-2 · Cited by 725
Shah, M. A., Ramanathan, R. K., Ilson, D. H., Levnor, A., D'Adamo, D., O'Reilly, E., Tse, A., Trocola, R., Schwartz, L., Capanu, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.0887 · Cited by 406
Wilke, H., Preusser, P., Fink, U., Gunzer, U., Meyer, H. J., Meyer, J., Siewert, J. R., Achterrath, W., Lenaz, L., & Knipp, H. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.9.1318 · Cited by 308
ARTEAGA, C. (2002) · Seminars in Oncology · doi:10.1016/s0093-7754(02)70085-7 · Cited by 302
Arteaga, C. L. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.35642 · Cited by 228
Sun, W., Powell, M., O'Dwyer, P. J., Catalano, P., Ansari, R. H., & Benson, A. B. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.7988 · Cited by 214
Targeting the EGFR Pathway for Cancer Therapy
Johnston, J., Navaratnam, S., Pitz, M., Maniate, J., Wiechec, E., Baust, H., Gingerich, J., Skliris, G., Murphy, L., & Los, M. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706779026174 · Cited by 183
Lordick, F., Luber, B., Lorenzen, S., Hegewisch-Becker, S., Folprecht, G., Wöll, E., Decker, T., Endlicher, E., Röthling, N., Schuster, T., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605521 · Cited by 176
Clinical cancer research: An embattled species
Frei, E. (1982) · Cancer · doi:10.1002/1097-0142(19821115)50:10<1979::aid-cncr2820501002>3.0.co;2-d · Cited by 159
Cited by
Ouyang, S., Li, H., Lou, L., Huang, Q., Zhang, Z., Mo, J., Li, M., Lu, J., Zhu, K., Chu, Y., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102317 · Cited by 507
Signaling pathways and therapeutic interventions in gastric cancer
Lei, Z.-N., Teng, Q.-X., Tian, Q., Chen, W., Xie, Y., Wu, K., Zeng, Q., Zeng, L., Pan, Y., Chen, Z.-S., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01190-w · Cited by 322
Parama, D., Boruah, M., Yachna, K., Rana, V., Banik, K., Harsha, C., Thakur, K. K., Dutta, U., Arya, A., Mao, X., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118182 · Cited by 155
Mangiferin prevents the growth of gastric carcinoma by blocking the PI3K-Akt signalling pathway
Du, M., Wen, G., Jin, J., Chen, Y., Cao, J., & Xu, A. (2018) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000583 · Cited by 25
Gao, W., & Yang, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.881015 · Cited by 13
Metadata
- Authors
- Song, Z., Wu, Y., Yang, J., Yang, D., & Fang, X.
- Venue
- Tumor Biology
- Publisher
- SAGE Publications
- Published
- 2017-07
- Volume
- 39
- Issue
- 7
- Pages
- 101042831771462
- ISSN
- 1010-4283 (ISSN-L)
- 1423-0380
- OpenAlex
- W2735126203
- Cited by
- 924
- References
- 30
- FWCI
- 41.51
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progress in the treatment of advanced gastric cancer. https://app.cochat.ai/papers/10.1177/1010428317714626
- The paper
- Song, Z., Wu, Y., Yang, J., Yang, D., & Fang, X. (2017). Progress in the treatment of advanced gastric cancer. Tumor Biology. https://doi.org/10.1177/1010428317714626
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.